The influence of glutathione metabolism on multidrug resistance in MRP-overexpressing cells

Drug Resistance Updates

Volumn 1, Issue 2, 1998, Pages 121-127

  Twentyman, Peter ^a   Bagrij, Tanya ^b  

^a United Kingdom Co ordinating Committee on Cancer Research   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0000510572     PISSN: 13687646     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-7646(98)80027-7     Document Type: Review

References (50)

1. Germann U.A. P-glycoprotein - a mediator of multidrug resistance in tumour cells. Eur J Cancer 32A (1996) 912-920
2. Loe D.W., Deeley R.G., and Cole S.P.C. Biology of the multidrug resistance associated protein. Eur J Cancer 32A (1996) 945-957
3. Jedlitschky G., Leier I., Buchholz U., Barnouin K., Kurz G., and Keppler D. Transport of glutathione, glucuronate and sulphate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res 56 (1996) 988-994
4. Cole S.P.C., Sparks K.E., Fraser K., et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54 (1994) 5902-5910
5. Lutzky J., Astor M.B., Taub R.N., et al. Role of glutathione and dependent enzymes in anthracycline-resistant HL60/AR cells. Cancer Res 49 (1989) 4120-4125
6. Mirksi S., Gerlach J.H., and Cole S.P.C. Multidrug resistance in a human small cell line selected in adriamycin. Cancer Res 47 (1987) 1780-1784
7. Slovak M.L., Hoeltge G.A., Dalton W.S., and Trent J.M. Pharmacological and biological evidence for differing mechanism of doxorubicin resistance in two human tumor cell lines. Cancer Res 48 (1988) 2793-2797
8. Kuiper C.M., Broxterman H.J., Baas F., et al. Drug transport variants without P-glycoprotein overexpression from a human squamous lung cancer cell line after selection with doxorubicin. J Cell Pharmacol 1 (1990) 35-41
9. McGrath T., and Center M.S. Adriamycin resistance in HL60 cells in the absence of detectable P-glycoprotein. Biochem Biophys Res Commun 145 (1987) 1171-1176
10. Zijlstra J.G., De Vries E., and Mulder N.H. Multifactorial drug resistance in an Adramycin-resistant human cell lung carcinoma cell line. Cancer Res 47 (1987) 1780-1784
11. Twentyman P.R., Fox N.E., Wright K.A., and Bleehen N.M. Derivation and preliminary characterisation of adriamycin resistant lines of human lung cancer cells. Br J Cancer 53 (1986) 529-537
12. Dusre L., Mimnaugh E.G., Myers C.E., and Sinha B.K. Potentiation of doxorubicin cytotoxicity by buthionine sulfoximine in multidrug-resistant human breast tumour cells. Cancer Res 49 (1989) 511-515
13. Tew K.D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res 54 (1994) 4313-4320
14. Ozols R.F., Louie K.G., Plowman J., et al. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione. Biochem Pharmacol 36 (1987) 147-153
15. Marquardt D., McCrone S., and Center M.S. Mechanisms of multidrug resistance in HL60 cells: detection of resistance-associated proteins with antibodies against synthetic peptides that correspond to the deduced sequence of P-glycoprotein. Cancer Res 50 (1990) 1426-1430
16. Cole S.P.C., Bhardwaj G., Gerlach J.H., et al. Overexpression of a novel transporter gene in multidrug resistant human lung cancer cell line. Science 258 (1992) 1650-1654
17. Grant C.E., Valdimarsson G., Hipfner D.R., Almquist K.C., Cole S.P.C., and Deeley R.G. Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res 54 (1994) 357-361
18. Zaman G.J.R., Flens M.J., van Leusden M.R., et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug efflux pump. Proc Natl Acad Sci USA 91 (1994) 8822-8826
19. Versantvoort C.H.M., Broxterman H.J., Bagrij T., Scheper R.J., and Twentyman P.R. Regulation by glutathione of drug transport in multidrug-resistant human lung tumour cell lines overexpressing multidrug resistance-associated protein. Br. J. Cancer 72 (1995) 82-89
20. Zaman G.J., Lankelma J., van Tellingen O., et al. Role of glutathione in the export of compounds from cells by the multidrug-resistance-associated protein. Proc Natl Acad Sci USA (1995) 7690-7694
21. Leier I., Jedlitschky G., Buchholz U., and Keppler D. Characterisation of the ATP-dependent leukotriene C4 export carrier in mastocytoma cells. Eur J Biochem 220 (1994) 599-606
22. Jedlitschky G., Leier I., Buchholz U., Center M., and Keppler D. ATP-dependent transport of glutathione S-conjugates by the multidrug resistance-associated protein. Cancer Res 54 (1994) 4833-4836
23. Leier I., Jedlitschky G., Buchholz V., et al. The MRP gene encodes an ATP-dependent export pump for leukotriene C4 and structurally related conjugates. J Biol Chem 269 (1994) 27807-27810
24. Müller M., Meijer C., Zaman G.J.R., et al. Overexpression of the gene encoding the multidrug resistance-associated protein results in increased ATP-dependent glutathione S-conjugate transport. Proc Natl Acad Sci USA 91 (1994) 13027-13033
25. Holló Z., Homolya L., Davis C.W., and Sarkadi B. Calcein accumulation as a fluorometric functional assay of the multidrug transporter. Biochimica et Biophysica Acta 1191 (1994) 385-388
26. Feller N., Broxterman H.J., Währer D.C., and Pinedo H.M. ATP-dependent efflux of calcein by the multidrug resistance protein (MRP): no inhibition by intracellular glutathione depletion. FEBS Lett 368 (1995) 385-388
27. Versantvoort C.H.M., Bagrij T., Wright K.A., and Twentyman P.R. On the relationship between the probenecid-sensitive transport of daunorubicin or calcein and the glutathione status of cells overexpressing the multidrug resistance-associated protein (MRP). Int. J Cancer 63 (1995) 855-862
28. Ishikawa T., Bao J.J., Yamane Y., et al. Coordinated induction of MRP/GS-X pump and gamma-glutamylysteine syuthetcie by heavy metals in human leukemia cells. J Biol Chem 271 (1996) 14981-14988
29. Ishikawa T., Akimaru K., Kuo M.T., Priebe W., and Suzuki M. How does the MRP/GS-X pump export doxorubicin?. J Natl Cancer Inst 87 (1995) 1639-1640
30. Broxterman H.J., Heijn M., and Lankelma J. Re: How does the MRP/GS-X pump export doxorubicin?. J Natl Cancer Inst 88 (1996) 466-468
31. Keppler D., Leier I., Jedlitschky G., Mayer R., and Buchler M. The function of the multidrug resistance proteins (MRP and cMRP) in drug conjugate transport and hepatobiliary exertion. Adv Enzyme Regul 36 (1996) 17-29
32. Kool M., de Haas M., Scheffer G.L., et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4 and MRP5, homologues of the multidrug resistance-associated protein gene (MRPI), in human cancer cell lines. Cancer Res 57 (1997) 3537-3547
33. Loe D.W., Almquist K.C., Deeley R.G., and Cole S.P. Multidrug resistance protein (MRP)-mediated transport of leukotriene C4 and chemotherapeutic agents in membrane vesicles. Demonstration of glutathione-dependent vincristine transport. J Biol Chem 271 (1996) 9675-9682
34. Loe D.W., Almquist K.C., Cole S.P., and Deeley R.G. ATP-dependent 17 beta-estradiol 17-(beta-D-glucuronide) transport by multidrug resistance protein (MRP). Inhibition by cholestatic steroids. J Biol Chem 271 (1996) 9683-9689
35. Stride B.D., Grant C.E., Loe D.W., Hipfner D.R., Cole S.P.C., and Deeley R.G. Pharmacological characterisation of the murine and human orthologs of multidrug-resistance protein in transfected human embryonic kidney cells. Mol Pharmacol 52 (1997) 344-353
36. Shen H., Paul S., Breuninger L.M., et al. Cellular and in vitro transport of glutathione conjugates by MRP. Biochemistry 35 (1996) 5719-5725
37. Paul S., Breuninger L.M., Tew K.D., Shen H., and Kruh G.D. ATP-dependent uptake of natural product cytotoxic drugs by membrane vesicles establishes MRP as a broad specificity transporter. Proc Natl Acad Sci USA 93 (1996) 6929-6934
38. Correction in Biochemistry 36 (1997) 13972
39. Heijn M., Hooijberg J., Scheffer G., Szabo G., Westerhoff H., and Lankelma J. Anthracyclines modulate multidrug resistance protein (MRP) mediated organic organic transport. Biochimica et Biophysica Acta 1326 (1997) 12-22
40. Loe D.W., Stewart R.K., Massey T.E., Deeley R.G., and Cole S.P. ATP-dependent transport of aflatoxin BI and its glutathione conjugates by the product of the multidrug resistance protein (MRP) gene. Mol Pharmacol 51 (1997) 1034-1041
41. Taguchi Y., Yoshida A., Takada Y., Komano T., and Ueda K. Anti-cancer drugs and glutathione stimulate vanadate-induced trapping of nucleotide in multidrug resistance-associated protein (MRP). FEBS Lett 401 (1997) 11-14
42. Chang X.B., Hou Y.X., and Riordan J.R. ATPase activity of purified multidrug resistance-associated protein. J Biol Chem 272 (1997) 30962-30968
43. Hooijberg J.H., Broxterman H.J., Heijn M., Fles D., Lankelma J., and Pinedo H.M. Modulation by (iso)flavonoids of the ATPase activity of the multidrug resistance protein. FEBS Lett 413 (1997) 344-348
44. Rappa G., Lorico A., Flavell R.A., and Sartorelli A.C. Evidence that the multidrug resistance protein (MRP) functions as a co-transporter of glutathione and natural product toxins. Cancer Res 57 (1997) 5232-5237
45. Lorico A., Rappa G., Finch R.A., Yang D., Flavell R.A., and Sartorelli A.C. Disruption of the murine MRP (multidrug resistance protein) gene leads to increased sensitivity to etoposide (VP-16) and increased levels of glutathione. Cancer Res 57 (1997) 5238-5242
46. Wijnholds J., Evers R., Van Leusden M.R., et al. Increased sensitivity to anticancer drugs and decreased inflammatory response in mice lacking the multidrug resistance-associated protein. Nature Medicine 3 (1997) 1275-1279
47. Vanhoefer U., Cao S., Minderman H., et al. Buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Clin Cancer Res 2 (1996) 1961-1968
48. O'Dwyer P.J., Hamilton T.C., LaCreta F.P., et al. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer. J Clin Oncol 14 (1996) 249-256
49. Bailey H., Ripple G., Tutsch K., et al. Phase I study of continuous-infusion L-S, R-buthionine sulfoximine with intravenous melphalan. J Natl Cancer Inst 89 (1997) 1789-1796
50. Manzano R.G., Wright K., and Twentyman P.R. Modulation by acrolein and chloroacetaldehyde of multidrug resistance-associated protein (MRP). Clin Cancer Res 2 (1996) 1321-1326